Depression, depressive symptoms, and rate of hippocampal atrophy in a longitudinal cohort of older men and women

Psychol Med. 2015 Jul;45(9):1931-44. doi: 10.1017/S0033291714003055. Epub 2015 Apr 21.

Abstract

Background: Several studies have reported smaller hippocampal volume (HcV) in depression patients; however, the temporality of the association remains unknown. One proposed hypothesis is that depression may cause HcV loss. This study evaluates whether previous depression and recent depressive symptoms are associated with HcV and HcV loss.

Method: We used a prospective cohort of older adults (n = 1328; age = 65-80 years) with two cerebral magnetic resonance imaging examinations at baseline and 4-year follow-up. Using multivariable linear regression models, we estimated, in stratified analyses by gender, the association between indicators of history of depression and its severity (age at onset, recurrence, hospitalization for depression), proximal depressive symptoms [Center for Epidemiologic Studies-Depression (CES-D) scale], baseline antidepressant use, and the outcomes: baseline HcV and annual percentage change in HcV.

Results: At baseline, women with more depressive symptoms had smaller HcV [-0.05 cm3, 95% confidence interval (CI) -0.1 to -0.01 cm3 per 10-unit increase in CES-D scores]. History of depression was associated with a 0.2% faster annual HcV loss in women (95% CI 0.01-0.36%). More baseline depressive symptoms and worsening of these symptoms were also associated with accelerated HcV loss in women. No associations were observed in men. Treatment for depression was associated with slower HcV loss in women and men.

Conclusions: While only concomitant depressive symptoms were associated with HcV, both previous depression and more proximal depressive symptoms were associated with faster HcV loss in women.

Keywords: Aging; atrophy; cohort studies; depression; hippocampus; imaging.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Antidepressive Agents / therapeutic use
  • Atrophy
  • Cohort Studies
  • Depression / drug therapy
  • Depression / pathology*
  • Depressive Disorder / drug therapy
  • Depressive Disorder / pathology*
  • Disease Progression
  • Female
  • Hippocampus / pathology*
  • Humans
  • Linear Models
  • Longitudinal Studies
  • Magnetic Resonance Imaging
  • Male
  • Multivariate Analysis
  • Prospective Studies
  • Severity of Illness Index
  • Sex Factors

Substances

  • Antidepressive Agents